- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 122,616,063
- Share change
- -815,425
- Total reported value
- $25,827,895,030
- Put/Call ratio
- 116%
- Price per share
- $210.60
- Number of holders
- 941
- Value change
- -$220,078,557
- Number of buys
- 382
- Number of sells
- 511
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
11%
|
15,757,405
|
$3,780,517,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.3%
|
13,721,952
|
$3,292,170,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.8%
|
11,537,299
|
$2,768,029,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
4.8%
|
7,011,506
|
$1,682,201,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.2%
|
6,184,455
|
$1,483,776,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.1%
|
4,536,480
|
$1,088,392,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
2,745,331
|
$656,969,000 | — | 31 Dec 2021 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.7%
|
2,523,402
|
$605,415,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,692,122
|
$405,973,000 | — | 31 Dec 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
1,566,220
|
$375,768,000 | — | 31 Dec 2021 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,555,205
|
$373,125,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1%
|
1,465,307
|
$351,556,000 | — | 31 Dec 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.92%
|
1,358,080
|
$325,833,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.81%
|
1,192,250
|
$286,043,000 | — | 31 Dec 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.79%
|
1,159,302
|
$278,139,736 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
1,131,357
|
$271,435,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.77%
|
1,131,063
|
$271,365,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.73%
|
1,073,807
|
$257,628,000 | — | 31 Dec 2021 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.66%
|
965,862
|
$231,730,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
949,240
|
$227,743,000 | — | 31 Dec 2021 | |
| Beutel, Goodman & Co Ltd. |
13F
|
Company |
0.62%
|
913,536
|
$219,175,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.62%
|
910,901
|
$218,544,000 | — | 31 Dec 2021 | |
| SOUTHEASTERN ASSET MANAGEMENT INC/TN/ |
13F
|
Company |
0.58%
|
858,523
|
$205,977,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.58%
|
855,772
|
$205,317,000 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.56%
|
816,571
|
$195,912,000 | — | 31 Dec 2021 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.54%
|
798,929
|
$191,679,000 | — | 31 Dec 2021 | |
| Amundi |
13F
|
Individual |
0.55%
|
803,594
|
$190,186,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
780,480
|
$187,253,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
741,737
|
$177,958,000 | — | 31 Dec 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.46%
|
670,925
|
$159,756,000 | — | 31 Dec 2021 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.44%
|
643,000
|
$154,269,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.42%
|
611,500
|
$146,711,000 | — | 31 Dec 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.41%
|
596,961
|
$143,222,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.39%
|
569,166
|
$136,554,000 | — | 31 Dec 2021 | |
| Swiss National Bank |
13F
|
Company |
0.39%
|
566,572
|
$135,932,000 | — | 31 Dec 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.38%
|
552,001
|
$132,436,000 | — | 31 Dec 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.36%
|
525,000
|
$125,958,000 | — | 31 Dec 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.34%
|
503,326
|
$120,758,000 | — | 31 Dec 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.33%
|
486,074
|
$116,619,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.32%
|
477,661
|
$114,600,000 | — | 31 Dec 2021 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.32%
|
467,869
|
$112,252,000 | — | 31 Dec 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.31%
|
461,482
|
$110,719,000 | — | 31 Dec 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.31%
|
460,000
|
$110,363,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.31%
|
455,200
|
$109,212,000 | — | 31 Dec 2021 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.31%
|
451,111
|
$109,205,000 | — | 31 Dec 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.31%
|
453,400
|
$108,780,000 | — | 31 Dec 2021 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
0.31%
|
452,053
|
$108,457,000 | — | 31 Dec 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.31%
|
450,741
|
$108,142,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.28%
|
412,888
|
$99,060,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.28%
|
411,169
|
$98,648,000 | — | 31 Dec 2021 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2022
As of 31 Mar 2022,
BIOGEN INC. - Common Stock (BIIB) was held by
941 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,616,063 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Clearbridge Investments, LLC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, and Legal & General Group Plc.
This page lists
944
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
996
Q1 2022 holders
941
Holder diff
-55
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.